A detailed history of State Street Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, State Street Corp holds 33,852,215 shares of LLY stock, worth $27 Billion. This represents 1.24% of its overall portfolio holdings.

Number of Shares
33,852,215
Previous 33,877,562 0.07%
Holding current value
$27 Billion
Previous $30.7 Billion 2.22%
% of portfolio
1.24%
Previous 1.36%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $19.6 Million - $24.3 Million
-25,347 Reduced 0.07%
33,852,215 $30 Billion
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $276 Million - $346 Million
-381,004 Reduced 1.11%
33,877,562 $30.7 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $279 Million - $373 Million
471,239 Added 1.39%
34,258,566 $26.7 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $200 Million - $236 Million
380,469 Added 1.14%
33,787,327 $19.7 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $205 Million - $283 Million
-471,559 Reduced 1.39%
33,406,858 $17.9 Billion
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $225 Million - $301 Million
642,274 Added 1.93%
33,878,417 $15.9 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $149 Million - $175 Million
-478,944 Reduced 1.42%
33,236,143 $11.4 Billion
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $42.6 Million - $49.7 Million
132,615 Added 0.39%
33,715,087 $12.3 Billion
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $49.9 Million - $56.9 Million
168,444 Added 0.5%
33,582,472 $10.9 Billion
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $94.7 Million - $111 Million
-339,894 Reduced 1.01%
33,414,028 $10.8 Billion
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $41.3 Million - $51.3 Million
-175,942 Reduced 0.52%
33,753,922 $9.67 Billion
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $183 Million - $227 Million
813,983 Added 2.46%
33,929,864 $9.37 Billion
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $41.7 Million - $51.4 Million
188,305 Added 0.57%
33,115,881 $7.65 Billion
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $76.1 Million - $98.4 Million
421,475 Added 1.3%
32,927,576 $7.56 Billion
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $158 Million - $205 Million
-962,779 Reduced 2.88%
32,506,101 $6.07 Billion
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $191 Million - $253 Million
-1,466,238 Reduced 4.2%
33,468,880 $5.65 Billion
Q3 2020

Nov 10, 2020

SELL
$146.22 - $169.13 $258 Million - $298 Million
-1,762,927 Reduced 4.8%
34,935,118 $5.17 Billion
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $48.2 Million - $58 Million
-353,117 Reduced 0.95%
36,698,045 $6.03 Billion
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $4.41 Billion - $5.46 Billion
37,051,162 New
37,051,162 $5.14 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.